Tim Anderson
Tim Anderson
Timothy Devon Andersonis an American professional baseball shortstop for the Chicago White Sox of Major League Baseball. Anderson played college baseball at East Central Community College, and was selected in the first round of the 2013 MLB draft by the White Sox. He made his MLB debut on June 10, 2016...
ProfessionBaseball Player
Date of Birth23 June 1993
market top
This is the top of the market in Evanston.
forward good looks moves moving
Anything that moves it forward is a good thing, and this looks like it's moving forward.
advantage area great hope schools start
This is great news. I really hope other schools in the area will take advantage of this and start participating.
areas brings deal good management shows
This is a pretty good deal for King. It brings them into new therapeutic areas and shows management is aggressive.
ahead court district move seldom surprising
This is a surprising move because seldom are 'at risk' launches done ahead of having even a district court ruling.
case cold hope
Our hope (in this case) is we will get a cold hit, ... It's important that we put this case to rest.
fda follow full
I think that the FDA will follow up with full approval,
washed
I think that the stock's probably washed out for a while,
dozen fairly half jump
Half a dozen will jump in fairly quickly.
burnt fortune good great hole knocking last putt
I had the good fortune of knocking my 2-3-foot putt in on the last hole and Doug's just burnt the edge. He was a great competitor.
addition goes homes single taken technician
In addition to that, he does not go into customers' homes alone. I have another technician that goes with him on every single job. We've taken precautions.
currently estimates global group multiple trades
The global pharmaceutical group multiple on 2006 earnings-per-share estimates is currently about 15 times, and Pfizer currently trades at 10.9 times.
acting companies company couple facing happen happens ironically run supposed turnaround
The company's not going out of business, but ironically it's acting like a cyclical, which drug companies aren't supposed to do. The turnaround may not happen for a couple of years, but it's a well run company that just happens to be facing a lot of problems.
bristol company concern decent drop far next patent shoe
The concern is that Bristol could be the next shoe to drop as far as patent expiration and reining in the numbers, ... But the company has a pretty decent late-stage pipeline.